pubmed-article:3657711 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3657711 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:3657711 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
pubmed-article:3657711 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
pubmed-article:3657711 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
pubmed-article:3657711 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3657711 | pubmed:dateCreated | 1987-11-6 | lld:pubmed |
pubmed-article:3657711 | pubmed:abstractText | Poor results with 131I-meta-iodobenzylguanidine (MIBG) therapy have been obtained in two children with stage IV neuroblastoma treated after partial surgery and unsatisfactory combination chemotherapy. Both patients' response to treatment (four and three 1-month-spaced courses, respectively; cumulative administration of 11.9 and 9.2 GBq) has been characterized by a low isotope concentration in the primary tumor and in the multiple bone metastases and by bone marrow uptake with final severe hematological toxicity. A slight decrease in the primary tumor's volume was observed in one patient at a cumulative dose of 85 Gy; there was no change in the other's at 42 Gy. At an initial, greater isotope concentration delivering 103 Gy, some bone metastases displayed a sharp decrease in uptake that persisted in the successive courses. For both patients a progressive spreading of new tumor localisation in the bones and finally in the soft tissues was observed. | lld:pubmed |
pubmed-article:3657711 | pubmed:language | eng | lld:pubmed |
pubmed-article:3657711 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3657711 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3657711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3657711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3657711 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3657711 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3657711 | pubmed:issn | 0098-1532 | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:MussaG CGC | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:MadonEE | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:GraziaGG | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:SilvestroLL | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:FaveroAA | lld:pubmed |
pubmed-article:3657711 | pubmed:author | pubmed-author:CottinoFF | lld:pubmed |
pubmed-article:3657711 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3657711 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:3657711 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3657711 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3657711 | pubmed:pagination | 216-9 | lld:pubmed |
pubmed-article:3657711 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:meshHeading | pubmed-meshheading:3657711-... | lld:pubmed |
pubmed-article:3657711 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3657711 | pubmed:articleTitle | 131I-metaiodobenzylguanidine treatment in neuroblastoma: report of two cases. | lld:pubmed |
pubmed-article:3657711 | pubmed:affiliation | Nuclear Medicine Service, Ospedale Mauriziano, Torino, Italy. | lld:pubmed |
pubmed-article:3657711 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3657711 | pubmed:publicationType | Case Reports | lld:pubmed |